Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (161-170 of 389) with videos related to

Pageof 39
Sort By:
Journal of Neurochemistry|February 16, 2006
Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient miceNeil J Anderson, Isabelle Seif, David J Nutt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 6, 2015
Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant EfficacySarah A Stuart, Paul Butler, Marcus R Munafò, et al.
Neuroscience Letters|July 3, 2007
The effect of 1-(4,5-dihydro-1H-imidazol-2-yl) isoquinoline on monoamine release and turnover in the rat frontal cortexHaya Abu Ghazaleh, Maggie D Lalies, Stephen M Husbands, et al.
Synapse (New York, N.Y.)|May 12, 2007
The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET studyAndrew J Montgomery, Anne R Lingford-Hughes, Alice Egerton, et al.
Nutrients|September 23, 2022
Functional Alternatives to AlcoholDavid J Nutt, Robin J Tyacke, Meg Spriggs, et al.
Neuropharmacology|June 10, 2014
The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imagingDarren R Quelch, Sarah L Withey, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|February 27, 2021
Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trialMarilia Gougoulaki, Glyn Lewis, David J Nutt, et al.
Human Brain Mapping|May 27, 2015
Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybinAlexander V Lebedev, Martin Lövdén, Gidon Rosenthal, et al.
Current Drug Abuse Reviews|December 19, 2012
Single chemical entity legal highs: assessing the risk for long term harmCarolyn B McNabb, Bruce R Russell, Daniele Caprioli, et al.
Journal of Psychopharmacology (Oxford, England)|September 20, 2024
Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-beingValerie Bonnelle, Amanda Feilding, Fernando E Rosas, et al.
Pageof 39

Showing results (161-170 of 389) with videos related to

Sort By:
Pageof 39
Journal of Neurochemistry|February 16, 2006
Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient miceNeil J Anderson, Isabelle Seif, David J Nutt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 6, 2015
Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant EfficacySarah A Stuart, Paul Butler, Marcus R Munafò, et al.
Neuroscience Letters|July 3, 2007
The effect of 1-(4,5-dihydro-1H-imidazol-2-yl) isoquinoline on monoamine release and turnover in the rat frontal cortexHaya Abu Ghazaleh, Maggie D Lalies, Stephen M Husbands, et al.
Synapse (New York, N.Y.)|May 12, 2007
The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET studyAndrew J Montgomery, Anne R Lingford-Hughes, Alice Egerton, et al.
Nutrients|September 23, 2022
Functional Alternatives to AlcoholDavid J Nutt, Robin J Tyacke, Meg Spriggs, et al.
Neuropharmacology|June 10, 2014
The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imagingDarren R Quelch, Sarah L Withey, David J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|February 27, 2021
Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trialMarilia Gougoulaki, Glyn Lewis, David J Nutt, et al.
Human Brain Mapping|May 27, 2015
Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybinAlexander V Lebedev, Martin Lövdén, Gidon Rosenthal, et al.
Current Drug Abuse Reviews|December 19, 2012
Single chemical entity legal highs: assessing the risk for long term harmCarolyn B McNabb, Bruce R Russell, Daniele Caprioli, et al.
Journal of Psychopharmacology (Oxford, England)|September 20, 2024
Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-beingValerie Bonnelle, Amanda Feilding, Fernando E Rosas, et al.
Pageof 39